Quantcast

Latest ovarian cancer Stories

2014-05-05 10:12:05

Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Dr. Susanna Greer, associate professor of biology, and research partners at the University of Georgia have identified two enzymes that suppress proteins that are important for regulating cell survival and chemoresistance in ovarian cancer. Their findings are published in the journal, PLOS ONE....

2014-05-05 08:29:46

SAN DIEGO, May 5, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin(®) (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers. The open-label study is expected to enroll up to 64...

2014-05-02 23:00:18

A 30-second Public Service Announcement (PSA) for the Mount Sinai Ovarian Cancer Risk Assessment program aired for the first time yesterday, May 1, on the iconic Toshiba Vision LED signboards in the heart of Times Square, New York City. The PSA will continue to broadcast every six minutes, 24-hours per day through May 15th. David Fishman, MD, Director and Founder of the Mount Sinai Ovarian Cancer Risk Assessment Program, Valisia LeKae, Broadway actress and ovarian cancer survivor and...

2014-04-28 08:31:08

-Specializes in Leading-Edge Biomarker Diagnostics for Gynecologic Cancers- AUSTIN, Texas, April 28, 2014 /PRNewswire/ -- Vermillion today launched ASPiRA LABS, which will specialize in applying the latest biomarker-based technologies to address critical needs in the management of gynecologic cancers. ASPiRA LABs will provide expert diagnostic processing and results using a state-of-the-art biomarker-based diagnostic algorithm to inform clinical decision making and advance...

2014-04-25 23:05:35

MarketOptimizer.org offers adds latest reports on Metastatic Ovarian and Prostate Cancer Market to its store. Dallas, TX (PRWEB) April 25, 2014 The report provides data on the Metastatic Ovarian & Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Ovarian & Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the...

2014-04-23 23:10:18

According to a new Korean study, a new method of diagnosing bladder cancer could “augment or replace” current approaches. Raleigh, NC (PRWEB) April 23, 2014 Cancer researchers in Korea say they have developed a simpler and less invasive way to diagnose bladder cancer from a urine sample. Details of the new study have just been posted on the Cancer Monthly website. Click here to learn more. Scientists with the Natural Product Research Institute at Seoul National University have...

2014-04-20 23:01:14

A federal jury’s decision to award billions of dollars in damages to a bladder cancer patient who took Actos could mean that others in the same situation may also have a right to seek compensation. Raleigh, NC (PRWEB) April 20, 2014 Last week, the Osaka, Japan-based company that produces the diabetes drug Actos and their American marketing partner Eli Lilly were ordered to pay more than $9 billion because Takeda allegedly concealed cancer risks associated with its Actos diabetes drug....

2014-04-17 23:08:10

In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights if they are diagnosed. Raleigh, NC (PRWEB) April 17, 2014 Cancer information site Cancer Monthly is advising Actos users to be aware of the symptoms of bladder cancer after a jury in the U.S. District Court for Western Louisiana concluded...

2014-04-17 08:28:08

Company also announces designation of Orphan Drug Status by FDA for VTX-2337 in Ovarian Cancer SEATTLE, April 17, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc. today announced that enrollment has been completed in GOG-3003 (NCT01666444), a randomized, placebo-controlled Phase 2 trial of VTX-2337 in combination with Pegylated Liposomal Doxorubicin (PLD) in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer who have failed prior...

2014-04-15 08:29:16

Trial Will Evaluate Investigational Compound's Efficacy and Safety as an Addition to Standard Chemotherapy in Previously-Untreated Patients NORTH CHICAGO, Ill., April 15, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced the initiation of a global Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer (NSCLC). The trial...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related